Duopa (carbidopa/levodopa) — United Healthcare
advanced Parkinson’s disease
Initial criteria
- Diagnosis of advanced Parkinson’s Disease
- AND patient experiences a wearing 'off' phenomenon that cannot be managed by increasing the dose of oral levodopa
- AND has undergone or has planned placement of a procedurally placed tube
Reauthorization criteria
- Documentation of positive clinical response to Duopa therapy
Approval duration
12 months